Business Description
Stallergènes SA
ISIN : FR0000065674
Description
Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.98 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.48 | |||||
| Interest Coverage | 17.56 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.3 | |||||
| Beneish M-Score | -2.73 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year Book Growth Rate | -4.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 1.6 | |||||
| Days Inventory | 218.78 | |||||
| Days Sales Outstanding | 43.51 | |||||
| Days Payable | 80.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.55 | |||||
| 5-Year Yield-on-Cost % | 1.55 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.66 | |||||
| Operating Margin % | 6.34 | |||||
| Net Margin % | 4.61 | |||||
| ROE % | 2.77 | |||||
| ROA % | 2.28 | |||||
| ROIC % | 3.25 | |||||
| ROC (Joel Greenblatt) % | 14.03 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.46 | |||||
| PE Ratio without NRI | 56.46 | |||||
| Shiller PE Ratio | 48.54 | |||||
| PS Ratio | 2.61 | |||||
| PB Ratio | 1.54 | |||||
| Price-to-Operating-Cash-Flow | 17.38 | |||||
| EV-to-EBIT | 37.81 | |||||
| EV-to-EBITDA | 17.04 | |||||
| EV-to-Revenue | 2.41 | |||||
| Earnings Yield (Greenblatt) % | 2.64 | |||||
| FCF Yield % | 5.76 | |||||
| Forward Rate of Return (Yacktman) % | 14.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Stallergènes SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 3.12 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 46.03 - 59.39 | ||
| Shares Outstanding (Mil) | 13.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stallergènes SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stallergènes SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stallergènes SA Frequently Asked Questions
What is Stallergènes SA(XPAR:GENP)'s stock price today?
The current price of XPAR:GENP is €0.00. The 52 week high of XPAR:GENP is €59.39 and 52 week low is €46.03.
When is next earnings date of Stallergènes SA(XPAR:GENP)?
The next earnings date of Stallergènes SA(XPAR:GENP) is .
Does Stallergènes SA(XPAR:GENP) pay dividends? If so, how much?
The Dividend Yield % of Stallergènes SA(XPAR:GENP) is 1.55% (As of Today), Highest Dividend Payout Ratio of Stallergènes SA(XPAR:GENP) was 0.28. The lowest was 0.24. And the median was 0.26. The Forward Dividend Yield % of Stallergènes SA(XPAR:GENP) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers